TCS CEO corrects three major Nashik facts: Nida Khan was not HR head, unit not shut, no POSH complaints on record
Read More Pharma Industry News Alexion Pharmaceuticals to acquire Syntimmune for $1.2bn to boost rare disease drug pipeline In a significant move within the pharmaceutical industry, Alexion Pharmaceuticals, a leading global biopharma company, has announced its… bypharmanewsdailySeptember 30, 2018
